Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Down 12.6% in December

Idorsia Ltd (OTCMKTS:IDRSF) was the target of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 6,314,900 shares, a decline of 12.6% from the December 15th total of 7,229,000 shares. Based on an average daily trading volume, of 12,600 shares, the short-interest ratio is currently 501.2 days.

Idorsia Price Performance

Shares of IDRSF stock opened at $0.91 on Friday. Idorsia has a 12-month low of $0.70 and a 12-month high of $2.88. The business has a 50 day simple moving average of $0.98 and a 200 day simple moving average of $1.84.

About Idorsia

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.